Harris DW - Search Results

1

(S)-(-)-4-[4-[2-(isochroman-1-yl)ethyl]-piperazin-1-yl] benzenesulfonamide, a selective dopamine D4 antagonist.

TenBrink RE, Bergh CL, Duncan JN, Harris DW, Huff RM, Lahti RA, Lawson CF, Lutzke BS, Martin IJ, Rees SA, Schlachter SK, Sih JC, Smith MW. TenBrink RE, et al. Among authors: harris dw. J Med Chem. 1996 Jun 21;39(13):2435-7. doi: 10.1021/jm960084f. J Med Chem. 1996. PMID: 8691438 No abstract available.

2

Pharmacological characterization of U-101387, a dopamine D4 receptor selective antagonist.

Merchant KM, Gill GS, Harris DW, Huff RM, Eaton MJ, Lookingland K, Lutzke BS, Mccall RB, Piercey MF, Schreur PJ, Sethy VH, Smith MW, Svensson KA, Tang AH, Vonvoigtlander PF, Tenbrink RE. Merchant KM, et al. Among authors: harris dw. J Pharmacol Exp Ther. 1996 Dec;279(3):1392-403. J Pharmacol Exp Ther. 1996. PMID: 8968364

3

Renin inhibitors containing psi[CH2O] pseudopeptide inserts.

TenBrink RE, Pals DT, Harris DW, Johnson GA. TenBrink RE, et al. Among authors: harris dw. J Med Chem. 1988 Mar;31(3):671-7. doi: 10.1021/jm00398a029. J Med Chem. 1988. PMID: 3279210

4

1-(alkylamino)isochromans: hypotensives with peripheral and central activities.

McCall JM, McCall RB, TenBrink RE, Kamdar BV, Humphrey SJ, Sethy VH, Harris DW, Daenzer C. McCall JM, et al. Among authors: harris dw. J Med Chem. 1982 Jan;25(1):75-81. doi: 10.1021/jm00343a015. J Med Chem. 1982. PMID: 6123600

5

Purification of an endogenous digitalislike factor from human plasma for structural analysis.

Ludens JH, Clark MA, DuCharme DW, Harris DW, Lutzke BS, Mandel F, Mathews WR, Sutter DM, Hamlyn JM. Ludens JH, et al. Among authors: harris dw. Hypertension. 1991 Jun;17(6 Pt 2):923-9. doi: 10.1161/01.hyp.17.6.923. Hypertension. 1991. PMID: 1646171

6

Characterization of U-92016A as a selective, orally active, high intrinsic activity 5-hydroxytryptamine1A agonist.

McCall RB, Romero AG, Bienkowski MJ, Harris DW, McGuire JC, Piercey MF, Shuck ME, Smith MW, Svensson KA, Schreur PJ, et al. McCall RB, et al. Among authors: harris dw. J Pharmacol Exp Ther. 1994 Nov;271(2):875-83. J Pharmacol Exp Ther. 1994. PMID: 7965808

7

Design and synthesis of a potent and specific renin inhibitor with a prolonged duration of action in vivo.

Thaisrivongs S, Pals DT, Harris DW, Kati WM, Turner SR. Thaisrivongs S, et al. Among authors: harris dw. J Med Chem. 1986 Oct;29(10):2088-93. doi: 10.1021/jm00160a049. J Med Chem. 1986. PMID: 3531518

8

alpha-Methylproline-containing renin inhibitory peptides: in vivo evaluation in an anesthetized, ganglion-blocked, hog renin infused rat model.

Thaisrivongs S, Pals DT, Lawson JA, Turner SR, Harris DW. Thaisrivongs S, et al. Among authors: harris dw. J Med Chem. 1987 Mar;30(3):536-41. doi: 10.1021/jm00386a016. J Med Chem. 1987. PMID: 3546690

9

Mass spectral characterization of an endogenous digitalislike factor from human plasma.

Mathews WR, DuCharme DW, Hamlyn JM, Harris DW, Mandel F, Clark MA, Ludens JH. Mathews WR, et al. Among authors: harris dw. Hypertension. 1991 Jun;17(6 Pt 2):930-5. doi: 10.1161/01.hyp.17.6.930. Hypertension. 1991. PMID: 1646172

10

Development of an immunoassay for endogenous digitalislike factor.

Harris DW, Clark MA, Fisher JF, Hamlyn JM, Kolbasa KP, Ludens JH, DuCharme DW. Harris DW, et al. Hypertension. 1991 Jun;17(6 Pt 2):936-43. doi: 10.1161/01.hyp.17.6.936. Hypertension. 1991. PMID: 1646173

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

71 results

Search Page

Filters